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Binding of immunoglobulin M (IgM) antibodies from normal human serum to the surface of Plasmodium
falciparum-infected red blood cells (iRBC) has previously been demonstrated only in parasites that form
rosettes with uninfected red cells. We show that natural, nonspecific IgM but not IgG, IgA, IgD, or IgE also
binds to the surface of iRBC selected for adhesion to chondroitin sulfate A (CSA), a placental receptor for
parasites associated with malaria in pregnancy. The protease sensitivity of IgM-binding appears to match that
of CSA binding, suggesting that the two phenotypes may be mediated by the same parasite molecule. We also
show that a wide range of mouse monoclonal antibodies of the IgM class bind nonspecifically to CSA-selected
iRBC, an important consideration in the interpretation of immunological assays performed on these parasite
lines.
Variant antigens of Plasmodium falciparum located on the
surface of infected red blood cells (iRBC) allow malaria par-
asites to sequester via receptors at specific sites within the host
(21). In pregnancy-associated malaria, sequestration in the pla-
centa may be due to iRBC adhering to the glycosaminoglycan
chondroitin sulfate A (CSA) (4, 17), specific low-sulfated
forms of which are found at the placental syncytiotrophoblast
surface and within the intervillous spaces (1). Selection for
parasites that bind to CSA in the placenta is thought to be a
major factor leading to the pathology associated with malaria
in pregnancy (6).
Antibodies directed against CSA-binding parasites correlate
with increasing gravidity and increased protection from ma-
laria pathology in women from regions where malaria is en-
demic, suggesting that development of a protective vaccine
against pregnancy-associated malaria may be possible (18, 26,
41). P. falciparum erythrocyte surface antigens of the PfEMP-1
class, encoded by the var multigene family (3, 42), are candi-
dates for vaccinating antigens to induce such protective anti-
bodies. The Duffy binding-like (DBL)  and cysteine-rich in-
terdomain region domains of certain PfEMP-1 variants have
been proposed to mediate CSA binding (7, 13, 25). However,
some of the genes associated with CSA binding are commonly
expressed in many P. falciparum lines, including many nonpla-
cental and non-CSA-binding isolates (20, 32, 34). Definitive
identification of the candidate sequence(s) for inclusion in a
vaccine to protect against malaria in pregnancy therefore has
not yet been achieved.
Other adhesion properties of P. falciparum, such as the stick-
ing of mature parasitized cells to endothelial cells and rosetting
adhesion between infected and uninfected red blood cells, also
appear to be mediated by specific PfEMP-1 variants (2, 31).
Some of these adhesive interactions involve host serum pro-
teins. For example, rosetting parasites, associated with severe
malaria in African children (8, 30), frequently bind nonspecific
human immunoglobulin M (IgM) (11, 33, 37, 39, 43). Nonspe-
cific IgG binding has also recently been reported to be involved
in adherence of iRBC to placental sections (16). To study the
involvement of host immunoglobulin binding in parasite at-
tachment to placental receptors, we selected six parasite lines
for the CSA-binding phenotype. These selected parasites, to-
gether with the unselected parental lines, were tested for their
capacity to bind immunoglobulin from normal human serum.
MATERIALS AND METHODS
Parasites and culture. The parasites used in this study are listed in Table 1. All
parasite lines originated from peripheral blood samples with the exception of
Gb337, which was washed from an infected placenta delivered at the Albert
Schweitzer Hospital, Lambarene, Gabon. Parasite lines SD2H3 and SD202 were
from women from the Sudanese village of Daraweesh. The Busua line was from
a Danish male who contracted malaria in the village of Busua in Ghana. HB3 and
FCR3 are long-established laboratory clones from Honduras and the Gambia,
respectively. The selected clone FCR3CSA (36) was obtained from the Malaria
Research and Reference Reagent Resource Centre (American Type Culture
Collection). Clone TM284S2 was obtained from the Karolinska Institute, Stock-
holm, Sweden (16). All isolates had been grown in culture for several months
before testing. Parasites were grown in group O-positive erythrocytes under
standard conditions (29), in RPMI 1640 medium containing sodium bicarbonate
and 25 mM HEPES, supplemented with 20 mM glucose, 2 mM glutamine, 25 g
of gentamicin per ml, and 10% pooled normal human serum, with the pH
adjusted to between 7.2 and 7.4 with 1 M NaOH (complete medium). Cultures
were gassed with a mixture of 1% oxygen, 3% carbon dioxide, and 96% nitrogen.
CSA selection. In vitro selection for binding to CSA was carried out by
multiple rounds of panning with protocols similar to those published (9). Tro-
phozoite-stage parasite cultures were incubated in plastic petri dishes (Falcon
1008) which had been coated with 10 g of bovine tracheal CSA (Sigma) per ml
in phosphate-buffered saline (PBS) overnight and then preblocked for 2 h with
2% bovine serum albumin (BSA)–PBS. The cultures were incubated at 37°C with
gentle agitation for 1 h. Uninfected and unbound iRBC were washed off gently
until the plate was homogeneously clear and microscopic examination showed
only static, bound iRBC. Uninfected red blood cells in complete medium at 5%
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hematocrit were then added to the plates, which were kept under normal culture
conditions, harvested 24 h later, and maintained in culture. All parental parasite
lines were selected at least 10 times to give the high CSA-binding lines tested
here.
Differential recognition of CSA-selected parasites by serum from multigravid
women. All the parasite lines were tested by flow cytometry for their ability to
differentially recognize antibodies in serum from multigravid women relative to
serum from males from regions where malaria is endemic and to nonexposed
European patient controls (40). Erythrocytes were labeled with 0.1 mg of
ethidium bromide solution per ml per 105 erythrocytes to differentiate between
uninfected cells and the nucleic acid-containing parasitized cells. After washing,
the cells were incubated in 1 to 5 l of pooled adult male serum, pooled
multigravid female serum from a region where malaria is endemic (Ghana), or
control serum from Danish malaria-naïve donors. Cells were again washed and
incubated with goat anti-human immunoglobulin G (Dako, Glostrup, Denmark)
diluted 1:200, followed by washing and incubation with 100 l of fluorescein
isothiocyanate-conjugated rabbit anti-goat immunoglobulin (Dako) diluted 1:25
in PBS. All incubations were for 30 min at room temperature, followed by three
washes in 3 ml of PBS between each incubation step (twice before the last step).
Samples were kept overnight at 5°C before analysis on a Coulter Epics XL-MCL
flow cytometer (Coulter Electronics, Luton, United Kingdom). Uninfected and
infected cells were gated according to ethidium bromide fluorescence, and the
median value was used for the quantification of fluorescein isothiocyanate fluo-
rescence. Recognition of antibodies specific to the pool of serum from multi-
gravid women was scored relative to antibodies recognized in the pool of male
serum and from control serum from the malaria-naïve patients. All data were
analyzed with Win MDI software (http://facs.scrips.edu/software.html).
Immunofluorescence assay to detect human immunoglobulin. The immuno-
fluorescence assay (IFA) to detect human immunoglobulin on the surface of
iRBCs was carried out with unfixed parasite cultures at the mature pigmented
trophozoite stage (33). Because of known cross-reactivity in these assays between
some animal sera and infected and uninfected human cells (33), particular
attention was paid to the reagents used. Only monoclonal antibodies (MAbs) and
affinity-purified polyclonal antisera were used, and extensive isotype controls
were included. Briefly, aliquots of culture suspension at 2% hematocrit were
washed in PBS and resuspended in PBS–1% immunoglobulin-free BSA (Sigma).
Mouse MAbs to human IgG(Fc), IgG(Fab), IgM, IgA, IgD, IgE, IgG1, IgG2,
IgG3, and IgG4 (all Serotec) and matched isotype controls were added to give a
final concentration of 1 g/ml. These were incubated for 1 h on ice, with gentle
resuspension of the cells every 10 min.
All mouse MAbs used were of the IgG class. A polyclonal antiserum to human
IgG (Dako) was also tested at 1:20 dilution as described (33). After two washes
with 750 l of PBS, detection was carried out with highly cross-absorbed Alexa
Fluor 488-conjugated goat anti-mouse IgG (Molecular Probes) at 1:500 dilution
in PBS–1% BSA plus 4,6-diamidino-2-phenylindole (DAPI) at 1 g/ml for 45
min on ice, in the dark, with gentle mixing every 10 min. After washing, cells were
resuspended at 30% hematocrit in PBS–1% BSA and used to make a thin smear
on a clean microscope slide. After air drying, the smear was overlaid with a drop
of 1.25 mg of diazabicyclo-(2, 2,2)octane (DABCO) per ml in 50% glycerol–50%
PBS and a coverslip (22 by 22 mm). The edges of the coverslip were sealed with
nail varnish. Each set of assays was performed at least three times and read each
time by two independent observers. Slides were viewed on an Olympus BX-50
microscope, and images were recorded with a digital camera and OpenLab
software. The percentage of iRBCs binding IgM was determined by counting at
least 200 infected cells. Each culture was assessed for rosette-forming capacity
immediately prior to the IFA tests.
Assessment of rosetting. Parasite culture aliquots at 2% hematocrit were
stained with 25 g of ethidium bromide per ml, and wet preparations were
viewed by fluorescence microscopy with UV and white light simultaneously to
visualize both stained and unstained cells. Two hundred mature infected cells
were counted, with the binding of two or more uninfected cells constituting a
rosette. The rosette frequency is the percentage of mature iRBCs that formed
rosettes.
IFA to detect mouse IgM binding. To determine whether IgM from species
other than humans also binds to CSA-selected parasite lines, the culture medi-
um-derived human serum IgM was stripped from the iRBC surface by incubation
at 2% hematocrit with 200 mg of chloroquine diphosphate (pH 5.0) per ml for
1 h at 20°C (15). Preliminary experiments showed that this treatment removed all
detectable human IgM from the iRBC surface (data not shown). The cells were
then washed twice with 750 l of PBS and incubated for 1 h as above with 10 g
of mouse IgM MAbs raised to a variety of different antigens per ml (Table 2).
None of these IgM MAbs reacted with normal human red blood cells, as assayed
by IFA (data not shown). Cells were washed and incubated with a 1:200 dilution
of Alexa Fluor 488-conjugated goat anti-mouse IgM (Molecular Probes) for 45
min. Negative controls were incubated with PBS–1% BSA followed by the above
secondary antibody. Positive controls were incubated with 10% normal human
serum followed by mouse anti-human IgM MAb followed by Alexa Fluor 488-
conjugated goat anti-mouse IgG. Cells were washed, prepared, and viewed as
described for the IFA assays with human immunoglobulin.
Protease treatments. Aliquots of parasite cultures were treated with 1 g, 10
g, and 100 g of TPCK-treated trypsin (Sigma) per ml for 5 min at 37°C,
followed by 1 mg of soybean trypsin inhibitor per ml for 5 min at 37°C. Controls
were treated in the same way with PBS substituting for the enzyme. Cells were
washed three times in complete RPMI medium prior to IFA and binding assays.
CSA binding assays. Spots (3 l) of 10-g/ml CSA in PBS were placed on
marked positions on plastic petri dishes (Falcon 1007), interspersed with 3-l
spots of PBS–1% BSA as negative controls. Plates were incubated overnight in
a humid box at 4°C. Next morning, the spots were removed by suction, and the
plates were blocked by incubating with PBS–1% BSA for 2 h at 37°C. Then 2 ml
of parasite culture suspension at 5 to 10% parasitemia and 2% hematocrit in a
binding medium (pH 7.2) of RPMI 1640 without sodium bicarbonate and human
serum but with 1% immunoglobulin-free BSA was added to each plate. This was
incubated for 1 h at 37°C, with gentle resuspension of the cells every 10 min.
Plates were then washed gently with PBS 6 to 10 times with a plastic Pasteur
pipette, swirling the plate to remove unbound cells. Washing continued until all
background binding had been removed. Bound cells were fixed with 1% glutar-
aldehyde and stained with 5% Giemsa. Plates were viewed with an Olympus
BX-2 microscope, with oil immersion and a 100 objective. The number of cells
bound in 10 high-power fields in each spot was counted.
RESULTS AND DISCUSSION
Six parasite lines demonstrating high levels of CSA binding
were selected from parental lines by multiple rounds of pan-
ning on CSA. After selection, each line with the exception of
HB3CSA showed enhanced recognition by serum from multi-
gravid women relative to serum from males from regions
where malaria is endemic (Table 1). This confirms earlier ob-
servations that most CSA-selected lines are recognized by spe-
TABLE 1. Binding of nonspecific human IgM to CSA-selected
parasitesa
Parasite
isolate Origin
Selected for
CSA
binding
Recognized by
female but
not male
antibodies
% of iRBC
binding
IgM
SD2H3 Sudan No No 1
SD2H3CSA Yes Yes 74
SD202 Sudan No No 4
SD202CSA Yes Yes 94
Busua Ghana No No 9
BusuaCSA Yes Yes 91
Gb337 Gabon No No 2
Gb337CSA Yes Yes 79
HB3 Honduras No No 4
HB3CSA Yes No 47
FCR3 Gambia No No 4
FCR3CSA Yes Yes 88
a Results are given as the percentage of IgM-positive iRBC observed in a
representative experiment on each line. All lines were tested at least three times,
some as many as 10 times. Consistent results were obtained in all experiments.
There was variation in the time at which each culture reached sufficient density
to allow testing and also in the rate at which different lines lost their selected
adhesion property (27). This precluded averaging results, because the timing of
each test postselection will not be strictly comparable.
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cific antibodies in serum from women who have had children in
areas where malaria is endemic. This specific recognition is
also correlated with the acquisition of protection from the
adverse outcomes of malaria in pregnancy (26, 41).
The six CSA-selected and corresponding unselected paren-
tal lines were tested for natural antibody binding by IFA on
unfixed cells. Surprisingly, all six CSA-selected lines showed a
marked increase in binding of nonspecific human IgM to the
iRBC surface relative to the unselected parental lines (Table
1). This IgM, which was derived from normal human serum in
the parasite culture medium, was defined in a punctate pattern
(Fig. 1), characteristic of the reaction of antibodies with the
parasite-encoded knob-associated erythrocyte surface antigens
(3). We did not detect any binding to human IgG, IgA, IgD, or
IgE in any of the parasite lines tested (data not shown).
Nonspecific IgM binding has previously been reported to be
a common property of parasite isolates with the rosetting phe-
notype (11, 33, 37, 39, 43). All of these experimental lines were
therefore tested for rosetting. Neither the CSA-selected nor
the parental unselected parasites formed rosettes. This is con-
sistent with reports that the rosetting phenotype is rarely seen
in P. falciparum isolates from pregnant women (23, 28). These
results indicate that CSA binding is a second, unrelated para-
site adhesion phenotype closely associated with the ability to
bind nonspecific IgM from normal human serum. To our
knowledge, this is the first report of apparent coselection for
CSA binding and nonspecific IgM binding on the surface of P.
falciparum-infected erythrocytes. Interestingly, nonspecific
IgM has recently been reported to bind to the surface of
erythrocytes infected with another Apicomplexan parasite,
Babesia bigemina (14). It will be important in future work to
find out whether nonspecific binding of IgM is also a property
of fresh placental isolates and, if so, whether this property
correlates with their CSA-binding capacity.
In searching for potential malaria parasite adhesion recep-
tors in the placenta, it has been reported that clone TM284S2,
which does not bind CSA but binds to placental tissue, binds
nonspecific IgG and may use the Fc receptors on the syncy-
tiotrophoblast layer as a binding receptor (16). We found no
evidence for nonspecific IgG binding in any of the CSA binding
isolates we studied. Nor have we been able to repeat the
observation of an IgG binding phenotype in the TM284S2,
although we confirmed that this clone binds IgM and forms
large rosettes. Differences in technique and/or reagents used
may account for this discrepancy (see (33) for further discus-
sion). In particular, it was found that the use of polyclonal
antisera that are not affinity purified may give false-positive
results in IFA with P. falciparum (12, 33, 35). The IgG detected
in the initial report on TM284S2 (16) could be a false-positive
signal resulting from the use of such a polyclonal reagent.
In view of the nonspecific nature of human IgM binding, we
investigated whether IgM of other species might act in a sim-
ilar manner. We found that a variety of mouse monoclonal
antibodies of the IgM class raised against nonmalarial antigens
also bound to the CSA-selected but not the unselected iRBC
(Table 2). Nonspecific binding of mouse IgG MAbs was never
detected (data not shown). The ability of CSA-selected iRBC
to cross-react nonspecifically with both human and mouse IgM
has important implications for the use of IgM reagents in
assays with CSA-binding parasites. It has recently been re-
ported that mouse MAbs raised against the CSA-binding do-
main of a PfEMP-1 variant were pan-reactive with several
CSA-binding parasite lines (22). However, all of the MAbs
described experimentally in this report were of the IgM class.
There is therefore a possibility that the apparent pan-reactivity
between IgM monoclonal antibodies and CSA-binding isolates
FIG. 1. Photomicrograph of parasites of P. falciparum line
Gb337CSA binding nonspecific human IgM. Immunofluorescence was
detected with mouse anti-human IgM (Serotec) and Alexa Fluor 488-
conjugated goat anti-mouse IgG secondary antibody (green). Parasite
nuclei are stained blue with DAPI. An IgM-positive and an IgM-
negative infected human erythrocyte are shown.
TABLE 2. Binding of mouse IgM MAbs to the CSA-selected parasite line Gb337CSA
MAb Specificity Source or reference % IgM positivea
Human IgM-positive control Not applicable Human serum 78
Negative control (goat anti-mouse
IgM secondary antibody)
Not applicable Molecular
Probes
0
MAb 2040 Heparan sulfate Chemicon 80
SM phage antibody CD36 Sigma 74
MAb CS-56 Chondroitin sulfate Sigma 77
MAb MOPC-104E IgM isotype control Sigma 78
MAb TCN-1 Toxocara canis 24 60
MAb TCN-4 Toxocara canis 24 82
MAb TCN-8 Toxocara canis 24 82
a Data from a representative experiment are shown. Three further experiments gave consistent results. The unselected parental line Gb337 was also tested, and all
MAbs showed less than 2% positive infected cells by IFA.
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might be due to the nonspecific cross-reaction of mouse IgM to
the selected CSA-binding iRBC as shown here.
Previous studies on the IgM binding phenotype of rosetting
P. falciparum clones have suggested that the ligand for IgM on
the iRBC is the trypsin sensitive PfEMP-1 surface antigen (10,
16). PfEMP-1 proteins, particularly certain DBL domains of
these molecules, are also proposed to be the CSA-binding
ligands of iRBC (7, 13, 25). To determine whether PfEMP-1 is
involved in IgM binding to CSA-selected parasites, the pro-
tease sensitivity of IgM and CSA-binding was analyzed. With
the parasite line SD202CSA, we found that both IgM binding
and CSA binding could be abolished by treatment of iRBC
with low concentrations (1 g/ml) of trypsin (Fig. 2). Our
results are consistent with, though not proof of, the hypothesis
that PfEMP-1 can mediate both IgM and CSA binding. The
concentration of trypsin required to abolish CSA binding in
this parasite was somewhat lower than in some other reports
(5, 19). This might be due to the use of different forms of CSA,
in selection and binding assays, between the various studies. It
could also mean that antigenically and presumably conforma-
tionally distinct parasite variants may have different trypsin
sensitivities.
Among rosetting parasites, it has been suggested that a func-
tion of nonspecific IgM binding is to enhance interactions
between infected and uninfected cells in the host bloodstream,
for example, via IgM binding to complement receptors (11, 33,
37, 39, 43). Placental IgM binding could function in a similar
way, perhaps through binding to other surface receptors in
addition to CSA. An Fc receptor for human IgM has recently
been described (38), although it is not yet known whether this
receptor is present on the placenta. Adhesion to the multi-
meric 900-kDa IgM molecules could also permit multiple in-
teractions with the large, free, CSA-rich syncytial ‘knots’ abun-
dant in the placental circulation (1, 44). Cross-linking with
syncytial knots might inhibit clearance of such large bodies
through the venular exits from the placenta, confining large
numbers of mature parasites to the placental environment.
Study of the mechanisms of placental adhesion, together
with identification of the parasite antigens targeted by protec-
tive antibodies, is urgently needed to elucidate the pathology
of placental malaria and ultimately allow protective immunity
to be induced in women prior to their first pregnancy.
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